The Pandemic's Impact on the Pediatric Cancer Research Landscape

Tuesday, April 28th - 2PM EST

• How is the pandemic changing current cancer care services?
• What is the current state of open clinical trials and how will new, near-term trials be affected?
• What is the impact on emerging new therapies and translational research?
• Are there any silver linings to all of this for childhood cancer research?

These answers and more are discussed in this special episode for cancer families where leaders from COG, the NCI and the pharmaceutical industry lead a community discussion about the pandemic's impact on all aspects of pediatric cancer research including clinical trials and standard cancer care services, followed by Q&A with questions from families and attendees.

We are joined by:
• Peter Adamson, MD – former Chair, Children's Oncology Group (COG) and current Global Head, Oncology Development & Pediatric Innovation, Sanofi

• Mark Kieran, MD, PhD – Pediatric Clinical Trial Lead, Bristol Myers Squibb

• Jeffery J. Auletta, MD - Director of the Blood and Marrow Transplant (BMT) Program and the Host Defense and Immunocompromised Infectious Diseases Program at Nationwide Children's Hospital.

• Carol Thiele, Ph.D, Deputy Chief, National Cancer Institute (NCI) Pediatric Oncology Branch

• Prof. Pamela Kearns President, European Society of Pediatric Oncology (SIOPE), Director of Cancer Research UK Clinical Trials Unit

 

Moderated by: Timothy P. Cripe, MD, PhD – Chief of Hematology and Oncology at Nationwide Children’s Hospital

 

Hosted by: Solving Kids' Cancer US & UK, and Max Cure Foundation

Latest COVID-19 Insights from Doctors + Stories from the Frontline to inform Childhood Cancer Families & the General Community

Tuesday, March 31st - 1PM EST

Please join this timely webinar to hear expert opinions, real-life descriptions, ask questions, and share information on:
• Progress on containing and treating the virus
• Could viruses like COVID-19 be the new normal?
• Medical services to pediatric cancer patients – how much of a delay right now?
• Clinical research trials for cancer and other diseases on hold – impact to getting new treatments developed
• Sharing a personal story: Real life with COVID-19 from a family’s perspective in New York

 

Click here for the full Q&A document from this webinar.

Discussion on Impact of COVID-19 in the Pediatric Cancer Community

Tuesday, March 24th - 2PM EST

Listen to this informative webinar to hear from experts, answer questions, and share information on:
• An overview of COVID-19 pandemic: Fact versus fiction
• COVID-19: What are the risks to immunocompromised patients?
• Impact of COVID-19 on care and clinical research

 

Click here for the full Q&A document from this webinar.

 

ABOUT THE SPEAKERS

photo of Timothy P. Cripe, MD, PhD

Timothy P. Cripe, MD, PhD

Chief of Hematology and Oncology – Nationwide Children’s Hospital

Timothy P. Cripe, MD, PhD, is a principal investigator in the Center for Childhood Cancer and Blood Diseases in The Research Institute and chief of the Division of Hematology/Oncology and Bone Marrow Transplantation at Nationwide Children’s Hospital. His lab’s current research focuses on developing and testing new, targeted therapies for pediatric solid tumors and translating those findings into clinical studies. Dr. Cripe and his team investigate the use of viruses that selectively infect and kill cancer cells, study their utility for killing cancer stem cells, and were among the first in the country to launch clinical trials of attenuated viruses in children.

 

photo of Jeffery J. Auletta, MD

Jeffery J. Auletta, MD

Director of the Blood and Marrow Transplant (BMT) Program and the Host Defense and Immunocompromised Infectious Diseases – Nationwide Children’s Hospital

Jeffery Auletta, MD, is the Director of the Blood and Marrow Transplant (BMT) Program and the Host Defense and Immunocompromised Infectious Diseases (HD) Program at Nationwide Children’s Hospital. He is a physician in both Hematology/Oncology/BMT and Infectious Diseases at Nationwide Children’s Hospital. Dr. Auletta is a professor of Pediatrics at The Ohio State University College of Medicine. He is a member of the Leukemia Research Program at The NCI-designated Ohio State University Comprehensive Cancer Center and a member of the Center for Regenerative Medicine and Cell-based Therapies at The Ohio State University.